We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Young People’s Barriers and Facilitators of Engagement with Web-Based Mental Health Interventions for Anxiety and Depression: A Qualitative Study

    Background

    The prevalence of anxiety and depressive symptoms in young people have increased in many countries around the world. Web-based mental...

    Thi Quynh Anh Ho, Lidia Engel, ... Cathrine Mihalopoulos in The Patient - Patient-Centered Outcomes Research
    Article Open access 13 July 2024
  2. Social costs associated with fibromyalgia in Spain

    Background

    Fibromyalgia is a chronic rheumatic disease of unknown aetiology, highly disabling and mainly affecting women. The aim of our work is to...

    J Oliva-Moreno, C Vilaplana-Prieto in Health Economics Review
    Article Open access 13 July 2024
  3. Cost-Effectiveness of Dupilumab and Oral Janus Kinase Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis in Singapore

    Background

    Atopic dermatitis (AD) affects both adults and children, impacting their quality of life and productivity; however, traditional systemic...

    Clarence Ong, Jamaica Briones, ... Hwee-Lin Wee in PharmacoEconomics - Open
    Article Open access 13 July 2024
  4. Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico

    Low adherence to preventative medications against life-long health conditions is a major contributor to global morbidity and mortality. We...

    Omar Galárraga, Marta Wilson-Barthes, ... Don Operario in The European Journal of Health Economics
    Article 13 July 2024
  5. Predictors of High Healthcare Cost Among Patients with Generalized Myasthenia Gravis: A Combined Machine Learning and Regression Approach from a US Payer Perspective

    Background

    High healthcare costs could arise from unmet needs. This study used random forest (RF) and regression methods to identify predictors of...

    Maryia Zhdanava, Jacqueline Pesa, ... Nizar Souayah in Applied Health Economics and Health Policy
    Article Open access 13 July 2024
  6. Budget Impact Analysis of Olaparib for the Management of Patients with Homologous Recombination Repair (HRR)-Mutated Castration-Resistant Metastatic Prostate Cancer in Argentina

    Objectives

    The aim of this study was to perform a budget impact analysis (BIA) of introducing olaparib treatment for adult patients with metastatic...

    Natalia Espinola, Constanza Silvestrini, ... Federico Augustovski in PharmacoEconomics - Open
    Article Open access 13 July 2024
  7. Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges

    The article offers a comparative analysis of the influence of cost-effectiveness thresholds in the decision-making processes in financing policies,...

    Oscar Espinosa, Paul Rodríguez-Lesmes, ... Hernán Enríquez in Applied Health Economics and Health Policy
    Article Open access 12 July 2024
  8. Untangling the corruption maze: exploring the complexity of corruption in the health sector

    Background

    Healthcare corruption poses a significant threat to individuals, institutions, sectors, and states. Combating corruption is paramount for...

    Margit Sommersguter-Reichmann, Gerhard Reichmann in Health Economics Review
    Article Open access 12 July 2024
  9. ENTIMOS: Decision Support Tool Highlights Potential Impact of Non-intravenous Therapies for Multiple Sclerosis on Patient Care via Clinical Scenario Simulation

    Introduction

    Administration of intravenous (IV), high-efficacy treatments (HETs) for the treatment of multiple sclerosis (MS) poses a high resourcing...

    Richard Nicholas, Erik Scalfaro, ... Nicholas Adlard in PharmacoEconomics - Open
    Article Open access 11 July 2024
  10. How is Value Defined in Molecular Testing in Cancer? A Sco** Review

    Objective

    To identify how value is defined in studies that focus on the value of molecular testing in cancer and the extent to which broadening the...

    Alice Minhinnick, Francisco Santos-Gonzalez, ... Paula Lorgelly in Applied Health Economics and Health Policy
    Article Open access 09 July 2024
  11. Using a Patient-Centered Multicriteria Decision Analysis to Assess the Value of Multiple Sclerosis Treatments in the US: A Study Protocol

    Objective

    The engagement of patients and family caregivers in value assessment is pivotal since they provide valuable contributions to assessment...

    Surachat Ngorsuraches, Tim C. Lai, ... William Meador in PharmacoEconomics - Open
    Article Open access 09 July 2024
  12. Preferences for the Societal Impacts of a Pandemic when it Transitions into an Endemic: A Discrete Choice Experiment

    Background

    The stage of the pandemic significantly affects people’s preferences for (the societal impacts of) COVID-19 policies. No discrete choice...

    Niek Mouter, Tom Geijsen, ... Marijn de Bruin in The Patient - Patient-Centered Outcomes Research
    Article Open access 09 July 2024
  13. The EQ-5D-3L valuation study for Bermuda: using an on-line EQ-VT protocol

    Background

    In many countries, methods of economic evaluation and Health Technology Assessment are used to inform healthcare resource allocation...

    Henry Bailey, Bram Roudijk, Ricky Brathwaite in The European Journal of Health Economics
    Article Open access 09 July 2024
  14. The Role of Patient-Reported Outcomes to Measure Treatment Satisfaction in Drug Development

    Treatment satisfaction is a person’s rating of his or her treatment experience, including processes and outcomes. It is directly related to treatment...

    Carolina Navas, Alexandra Palmer Minton, Ana Maria Rodriguez-Leboeuf in The Patient - Patient-Centered Outcomes Research
    Article Open access 08 July 2024
  15. Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata

    Background

    For many decision makers in Health Technology Assessment the EQ-5D-5L is the standard measure of health-related quality of life (HRQL)....

    Andrew Lloyd, Daniel Aggio, ... Thomas Price in PharmacoEconomics - Open
    Article Open access 06 July 2024
  16. A Multi-dimensional Framework of Valued Output for Primary Care in England

    Improving efficiency and productivity are key aspects to ensure that general practices in England can meet the needs of a growing population with...

    Margherita Neri, Patricia Cubi-Molla, Graham Cookson in Applied Health Economics and Health Policy
    Article Open access 06 July 2024
  17. Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know

    There is increasing interest in the use of cure modelling to inform health technology assessment (HTA) due to the development of new treatments that...

    Nicholas R. Latimer, Mark J. Rutherford in PharmacoEconomics
    Article Open access 05 July 2024
  18. Cost-effectiveness of immune checkpoint inhibitors as a first-line therapy for advanced hepatocellular carcinoma: a systematic review

    Since 2017, immune checkpoint inhibitors (ICIs) have been available for the treatment of advanced hepatocellular carcinoma (HCC) or unresectable HCC,...

    Hongyu Gong, Siew Chin Ong, ... Meng Wang in Health Economics Review
    Article Open access 05 July 2024
  19. Discrete Choice Experiments to Elicit Patient Preferences for the Treatment of Major Depressive Disorder: A Systematic Review

    Background

    Individual preferences for treatment options for major depressive disorder can impact therapeutic decision making, adherence, and...

    Susan dosReis, Dafne Espinal Pena, ... Alejandro Amill-Rosario in The Patient - Patient-Centered Outcomes Research
    Article 05 July 2024
Did you find what you were looking for? Share feedback.